Health Technology Assessment (May 2005)
A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine
Abstract
No abstracts available.
Health Technology Assessment (May 2005)